127 results on '"Chen, Wilbur"'
Search Results
2. The Value of AI Innovations
3. Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
4. Shigella-Controlled Human Infection Models: Current and Future Perspectives
5. Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study
6. Going digital: implications for firm value and performance
7. Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS‐CoV‐2
8. Analyst Focus on AI and Corporate Demand for AI Technologies
9. Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond
10. The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination
11. A systems serology analysis of correlates of protection against cholera
12. Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial
13. Functional and structural modifications of influenza antibodies during pregnancy
14. Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021
15. Going Digital: Implications for Firm Value and Performance
16. How are Vaccines Assessed in Clinical Trials?
17. Contributors
18. Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
19. AE Reporting and Causality
20. A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model
21. A site assessment tool for inpatient controlled human infection models for enteric disease pathogens
22. Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach
23. The antibody landscapes against Group 1 and 2 influenza virus hemagglutinin following AS03 and MF59 adjuvanted H5N1 vaccination
24. Functional and structural modifications of influenza antibodies during pregnancy
25. The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions
26. National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines
27. Opportunities and Challenges in Developing a Cryptosporidium Controlled Human Infection Model for Testing Antiparasitic Agents
28. The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region
29. Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older
30. Functional and Structural Modifications of Influenza Antibodies During Pregnancy
31. Vaccine‐related major cutaneous reaction size correlates with cellular‐mediated immune responses after tularaemia immunisation
32. Understanding immunosenescence and its impact on vaccination of older adults
33. For now, it’s unethical to use human challenge studies for SARS-CoV-2 vaccine development
34. National Routine Adult Immunization Programs among World Health Organization Member States: An Assessment of Health Systems to Deploy Future SARS-CoV-2 Vaccines
35. Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults
36. The operational impact of deploying SARS-CoV-2 vaccines in countries of the WHO African Region
37. Going Digital: Implications for Firm Value and Performance.
38. COVID-19 and Lessons to Be Learned from Prior Coronavirus Outbreaks
39. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials
40. National Routine Adult Immunization Programs among World Health Organization Member States: An Assessment of Health Systems to Deploy Future SARS-CoV-2 Vaccines
41. Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
42. Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies
43. Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba
44. Mitigating Cholera in the Aftermath of Cyclone Idai
45. The way forward for ETEC controlled human infection models (CHIMs)
46. A comparison of Lyse-It to other cellular sample preparation, bacterial lysing, and DNA fragmentation technologies
47. Characteristics of regulatory T-cell populations before and after Ty21a typhoid vaccination in children and adults
48. Diversity of Salmonella Typhi-responsive CD4 and CD8 T cells before and after Ty21a typhoid vaccination in children and adults
49. A roadmap for enterotoxigenic Escherichia coli vaccine development based on volunteer challenge studies
50. Age-Associated Heterogeneity of Ty21a-Induced T Cell Responses to HLA-E Restricted Salmonella Typhi Antigen Presentation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.